Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
4,834.00    -54.00 (-1.10%)
Bid:
4,818.00
Ask:
4,828.00
Spread: 10.00 (0.208%)
Market Cap: $1.27t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Future Business Management Plan

29 Jun 2026 10:05

RNS Number : 1618K
Samsung Electronics Co. Ld
29 June 2026
 

Future BusinessManagement Plan (fair disclosure)

 

 

※ The following information contains forward-looking statements and is subject to change.

1. Future business plan

 Domestic investment vision for 2026-2040

 

 

2. Major details and implementation schedule

Purpose

To strengthen the competitiveness of the Company's core businesses

Details

Investment in the global cutting-edge semiconductor business, etc.

Implementation schedule

Start date

January 1, 2026

End date

December 31, 2040

Expected investment amount

Approximately KRW 2,450 trillion (including approximately KRW 2,100 trillion for the semiconductor business) . KRW 1,650 trillion for the Yongin semiconductor cluster and existing semiconductor complexes / KRW 400 trillion for Gwangju / DX, Display and other businesses . Construction of an HBM Fab in Onyang, Cheonan . Development of a global advanced semiconductor cluster in Gwangju . Construction of a humanoid robot production line in Gumi

Expected effects

Strengthened competitiveness of the Company's core businesses

3. Risk factors

 -

4. Date of Board resolution (Decision date)

 -

 

5. Information disclosure

Disclosing department

IR team

Recipients

Domestic and international investors, the media, etc.

Scheduled disclosure date and time

June 29, 2026, 5:10 p.m. (KST)

Event (venue)

National Briefing on the Three Mega Projects for Korea's Grand Leap Forward (The Presidential Office)

6. Contact information (Related department/Telephone Number)

IR team (02-2255-9000)

7. Other information material to investment decisions

The above mid- to long-term investment plan is provided as a guideline for reference based on the current market conditions. It is subject to change depending on future market conditions and changes in the Company's business environment.

Scheduled date of progress disclosure

Related disclosure

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLMLTMTMTMBF
Date   Source Headline
31st Aug 20223:44 pmRNS2022 Half-year Business Report
28th Jul 20228:57 amRNSCharitable Contribution
28th Jul 20228:48 amRNSTransaction with Affiliate Company
28th Jul 20228:42 amRNSQuarterly Dividend for Second Quarter 2022
28th Jul 20228:35 amRNS2022 2Q Earnings Release
7th Jul 20227:56 amRNSNotice of 2Q 2022 Earnings Release
7th Jul 20227:55 amRNS2Q 2022 Pre-Earnings Guidance
30th Jun 202210:01 amRNSSustainability Report 2022
31st May 202211:43 amRNSCorporate Governance Report FY2021
31st May 202211:02 amRNS2022 1Q Interim Business Report
18th May 202210:26 amRNSEarly Termination of Independent Director’s Term
29th Apr 20222:50 pmRNS2021 Business Report
28th Apr 202210:01 amRNSTransactions with Affiliated Companies
28th Apr 20229:49 amRNSTransactions with Affiliated Companies
28th Apr 20229:44 amRNSCharitable Contribution
28th Apr 20229:29 amRNSQuarterly Dividend for First Quarter 2022
28th Apr 20229:24 amRNS2022 1Q Earnings Release
21st Apr 20229:18 amRNSEarly Termination of Independent Director’s Term
21st Apr 20228:49 amRNSEarly Termination of Independent Director’s Term
7th Apr 20229:35 amRNSNotice of 1Q 2022 Earnings Release Schedule
7th Apr 20229:32 amRNS1Q 2022 Pre-Earnings Guidance
16th Mar 20229:10 amRNSTransaction with Affiliate Company
16th Mar 20229:08 amRNSAppointment of New Chief Executive Officer
16th Mar 20229:06 amRNSResults of the 53rd Annual General Meeting
17th Feb 202210:18 amRNSReference Material for 2022 AGM
17th Feb 20228:40 amRNS2021 Separate Financial Statements
17th Feb 20228:30 amRNS2021 Consolidated Financial Statements
15th Feb 202211:35 amRNSReference Material for 2022 AGM
15th Feb 202211:24 amRNSTransaction with Affiliate Company
15th Feb 202211:21 amRNSAppointment of New Chief Executive Officer
15th Feb 202211:16 amRNSCharitable Contribution
27th Jan 20227:05 amRNSYear-End Dividend for FY2021
27th Jan 20227:00 amRNS2021 4Q Earnings Release
7th Jan 20227:00 amRNSNotice of 4Q 2021 Earnings Release Schedule
7th Jan 20227:00 amRNS4Q 2021 Pre-Earnings Guidance
1st Dec 202110:03 amRNSCharitable Contributions
30th Nov 202112:52 pmRNS2021 3Q Interim Business Report
30th Nov 202111:15 amRNSTransactions with Affiliated Companies
24th Nov 20218:11 amRNSInvestment in Fabrication Plant
10th Nov 20217:55 amRNSAnnouncement of Investor Relations Event
28th Oct 20218:22 amRNSCharitable Contribution
28th Oct 20218:18 amRNSTransaction with Affiliate Company
28th Oct 20218:04 amRNSTransaction with Affiliate Company
28th Oct 20218:03 amRNSQuarterly Dividend for Third Quarter 2021
28th Oct 20217:59 amRNS2021 3Q Earnings Release
8th Oct 20218:05 amRNSNotice of 3Q 2021 Earnings Release Schedule
8th Oct 20218:04 amRNS3Q 2021 Pre-Earnings Guidance
31st Aug 202110:39 amRNS2021 Half-year Business Report
29th Jul 20218:12 amRNSRenewal of Property & Casualty Insurance Policy
29th Jul 20218:07 amRNSQuarterly Dividend for Second Quarter 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.